CL
TMO icon

Choreo LLC’s Thermo Fisher Scientific TMO Stock Holding History

Choreo LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.98M Buy
11,918
+690
+6% +$331K 0.07% 204
2026
Q1 		$5.52M Sell
11,228
-180
-2% -$97.7K 0.07% 202
2025
Q4 		$6.66M Buy
11,408
+320
+3% +$181K 0.08% 163
2025
Q3 		$5.38M Sell
11,088
-241
-2% -$112K 0.07% 193
2025
Q2 		$4.6M Sell
11,329
-14
-0.1% -$5.85K 0.06% 206
2025
Q1 		$5.65M Sell
11,343
-2,401
-17% -$1.3M 0.09% 162
2024
Q4 		$7.14M Buy
13,744
+1,947
+17% +$1.07M 0.1% 144
2024
Q3 		$7.23M Buy
11,797
+1,227
+12% +$726K 0.11% 137
2024
Q2 		$5.73M Buy
10,570
+7,366
+230% +$4.22M 0.1% 147
2024
Q1 		$1.86M Sell
3,204
-150
-4% -$84.2K 0.05% 189
2023
Q4 		$1.78M Buy
3,354
+1,755
+110% +$849K 0.05% 191
2023
Q3 		$810K Buy
1,599
+158
+11% +$84.2K 0.03% 215
2023
Q2 		$752K Sell
1,441
-32
-2% -$17.3K 0.03% 236
2023
Q1 		$849K Buy
1,473
+670
+83% +$378K 0.03% 224
2022
Q4 		$442K Buy
803
+105
+15% +$55.6K 0.02% 156
2022
Q3 		$354K Buy
698
+10
+1% +$5.6K 0.02% 153
2022
Q2 		$374K Buy
688
+31
+5% +$17.1K 0.02% 149
2022
Q1 		$388K Sell
657
-206
-24% -$118K 0.02% 162
2021
Q4 		$576K Sell
863
-80
-8% -$49.9K 0.03% 133
2021
Q3 		$539K Buy
943
+286
+44% +$157K 0.03% 129
2021
Q2 		$331K Hold
657
– – 0.02% 166
2021
Q1 		$300K Hold
657
– – 0.02% 155
2020
Q4 		$306K Sell
657
-15
-2% -$7.03K 0.02% 156
2020
Q3 		$297K Hold
672
– – 0.02% 147
2020
Q2 		$243K Sell
672
-41
-6% -$13.7K 0.02% 158
2020
Q1 		$202K Sell
713
-146
-17% -$46K 0.02% 166
2019
Q4 		$279K Buy
+859
New +$260K 0.03% 166

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Choreo LLC's TMO Position: Q2 2026 in Review

Choreo LLC increased its Thermo Fisher Scientific (TMO) stake by 6.1% in Q2 2026, buying an estimated $331K and bringing the position to 11,918 shares worth $5.98M. The position accounts for 0.07% of the portfolio, ranked #204.

Choreo LLC first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.23M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Choreo LLC held 11,918 shares of Thermo Fisher Scientific worth $5.98M as of Q2 2026.
  • Choreo LLC bought 690 Thermo Fisher Scientific shares in Q2 2026, an estimated $331K.
  • Thermo Fisher Scientific made up 0.07% of Choreo LLC's portfolio in Q2 2026, its #204 holding.
  • Choreo LLC first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Choreo LLC's Thermo Fisher Scientific position peaked at $7.23M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.